-transparent.png){kind=logo}
The authors found a high prevalence--43.4% of tardive dyskinesia in a sample of psychiatric outpatients, a population previously thought to be at nominal risk for development of this syndrome. There was no significant relationship between the presence of dyskinesia and age, sex, years of neuroleptic use, or various organic factors. The effects of dentures and of drug combinations are discussed, and it is noted that structured scales of dyskinesia and videotope recordings are important tools in diagnosing and following the course of dyskinesia.
Related Publications
G M Asnis, and
M A Leopold, and
R C Duvoisin, and
A H Schwartz
October 1981,
The American journal of psychiatry,
G M Asnis, and
M A Leopold, and
R C Duvoisin, and
A H Schwartz
January 1986,
Psychopharmacology bulletin,
G M Asnis, and
M A Leopold, and
R C Duvoisin, and
A H Schwartz
March 1981,
The Australian and New Zealand journal of psychiatry,
G M Asnis, and
M A Leopold, and
R C Duvoisin, and
A H Schwartz
January 1985,
Annals of the Academy of Medicine, Singapore,
G M Asnis, and
M A Leopold, and
R C Duvoisin, and
A H Schwartz
February 1992,
Clinical neuropharmacology,
G M Asnis, and
M A Leopold, and
R C Duvoisin, and
A H Schwartz
January 1980,
Psychopharmacology,
G M Asnis, and
M A Leopold, and
R C Duvoisin, and
A H Schwartz
December 1989,
The West Indian medical journal,
G M Asnis, and
M A Leopold, and
R C Duvoisin, and
A H Schwartz
June 1979,
Psychopharmacology,
G M Asnis, and
M A Leopold, and
R C Duvoisin, and
A H Schwartz
February 1985,
The Journal of clinical psychiatry,
G M Asnis, and
M A Leopold, and
R C Duvoisin, and
A H Schwartz
November 1977,
La Nouvelle presse medicale,
